Duopharma's Attributable Income Shrinks in Q1; Shares Down 2%

DuoPharma (KLSE:DPHARMA) booked an attributable income to shareholders of 11.9 million ringgit in Q1, compared with 13.6 million ringgit in the year ago period, according to a filing with the Malaysia

MT NewswiresMay 24 03:57

Duopharma Biotech Berhad (KLSE:DPHARMA) Investors Are Sitting on a Loss of 42% If They Invested Three Years Ago

Yahoo FinanceMay 23 19:54

Duopharma's 1Q Net Profit Down 33% on Higher Costs, Unfavorable Exchange Rates

Duopharma Biotech Bhd’s (KL:DPHARMA) net profit dropped 32.5% for the first quarter amid lower demand in the prescription pharmaceutical products, higher costs as well as unfavorable exchange rates.

The Edge MarketsMay 23 06:48

Duopharma Biotech Clinches MYR578 Million Supply Deals

Duopharma Biotech (KLSE:DPHARMA), through two wholly-owned subsidiaries, accepted 11 letters of offers from Pharmaniaga Logistics worth an aggregate 578 million ringgit for the supply of pharmaceutica

MT NewswiresMay 1 01:43

While Individual Investors Own 28% of Duopharma Biotech Berhad (KLSE:DPHARMA), Sovereign Wealth Funds Are Its Largest Shareholders With 51% Ownership

Yahoo FinanceApr 23 20:10

Are Duopharma Biotech Berhad's (KLSE:DPHARMA) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Yahoo FinanceMar 23 21:12